QRS duration and shortening to predict clinical response to cardiac resynchronization therapy in patients with end-stage heart failure.


Despite current selection criteria (NYHA Class III-IV, LVEF < 35%, QRS > 120 ms with LBBB), 30% of patients do not benefit from cardiac resynchronization therapy (CRT). The use of QRS duration as selection criteria for CRT has not been evaluated systematically yet. Accordingly, the value of QRS duration at baseline (and reduction in QRS duration after CRT… (More)


  • Presentations referencing similar topics